The present invention relates to a method for labeling a prostate-specific membrane antigen (PSMA) ligand with a radioactive isotope such as 68 Ga, 177 Lu, or 9 Y, and to a kit for carrying out this method. Radiolabeled PSMA ligands prepared by this method can be used for both imaging and therapy purposes.